Key players in Autologous Matrix-induced Chondrogenesis
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  Anika Therapeutics, Inc |
anika.com (opens in a new tab) | 66 reports |
| 2 | B. Braun Melsungen AG | — | 363 reports |
| 3 |  BioTissue AG |
biotissue.com (opens in a new tab) | 33 reports |
| 4 |  CartiHeal |
cartiheal.com (opens in a new tab) | 33 reports |
| 5 |  Geistlich Pharma AG |
geistlich.com (opens in a new tab) | 33 reports |
| 6 | JRI Orthopaedics Ltd | — | 33 reports |
Also active in Autologous Matrix-induced Chondrogenesis
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
| AlloSource |
|
| Aesculap AG |
|
| Kang Stem Biotech Co., Ltd. |
|
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Top trial sponsors in Autologous Matrix-induced Chondrogenesis
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
- AlloSource 2 active trials on ClinicalTrials.gov (opens in a new tab)
- Aesculap AG 2 active trials on ClinicalTrials.gov (opens in a new tab)
- Kang Stem Biotech Co., Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Autologous Matrix-induced Chondrogenesis reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Autologous Matrix-induced Chondrogenesis report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.